PROLIANCE Trademark

Trademark Overview


On Tuesday, November 15, 2016, a trademark application was filed for PROLIANCE with the United States Patent and Trademark Office. The USPTO has given the PROLIANCE trademark a serial number of 87237293. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, January 12, 2024. This trademark is owned by Proliance Surgeons, Inc., P.S.. The PROLIANCE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research
proliance

General Information


Serial Number87237293
Word MarkPROLIANCE
Filing DateTuesday, November 15, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, January 12, 2024
Registration Number5264094
Registration DateTuesday, August 15, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2017

Trademark Statements


Goods and ServicesMedical research

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 21, 2016
Primary Code042
First Use Anywhere DateThursday, January 31, 2002
First Use In Commerce DateThursday, January 31, 2002

Trademark Owner History


Party NameProliance Surgeons, Inc., P.S.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSeattle, WA 98004

Party NameProliance Surgeons, Inc., P.S.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSeattle, WA 98004

Party NameProliance Surgeons, Inc., P.S.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSeattle, WA 98004

Trademark Events


Event DateEvent Description
Friday, January 12, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, January 12, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, January 12, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 1, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 18, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, August 15, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, May 4, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 4, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 30, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 6, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 4, 2019REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Monday, December 31, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 15, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, May 30, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 20, 2017ASSIGNED TO LIE
Thursday, April 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 23, 2017ASSIGNED TO LIE
Tuesday, March 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 23, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 23, 2017NON-FINAL ACTION E-MAILED
Thursday, February 23, 2017NON-FINAL ACTION WRITTEN
Wednesday, February 22, 2017ASSIGNED TO EXAMINER
Monday, November 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 18, 2016NEW APPLICATION ENTERED

Related Keywords


proliance research medical